Notice: This company has been marked as potentially delisted and may not be actively trading. Longboard Pharmaceuticals (LBPH) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period H Lundbeck A/S (HLUNAC.XD)February 9, 2025 | finance.yahoo.comH. Lundbeck A/S (HLUN-A.CO)December 19, 2024 | finance.yahoo.comLongboard Pharmaceuticals' SWOT analysis: bexicaserin potential drives stock outlookDecember 19, 2024 | investing.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Shares Sold by Quantbot Technologies LPQuantbot Technologies LP cut its holdings in shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 90.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,813 shares ofDecember 8, 2024 | marketbeat.comLundbeck acquires all outstanding shares of Longboard PharmaDecember 5, 2024 | msn.com107,345 Shares in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Bought by Readystate Asset Management LPReadystate Asset Management LP purchased a new position in shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 107,345 shares of the company's stock, valuedDecember 5, 2024 | marketbeat.comParkman Healthcare Partners LLC Decreases Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Parkman Healthcare Partners LLC reduced its stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 29.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 491,272 shares of the company's stock after seDecember 4, 2024 | marketbeat.comFmr LLC Cuts Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Fmr LLC reduced its position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 1.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,350,099 shares of the company's stock after sellingDecember 4, 2024 | marketbeat.comVictory Capital Management Inc. Buys New Shares in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Victory Capital Management Inc. bought a new stake in shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 15,773 shares of the company's stock,November 30, 2024 | marketbeat.comAlly Bridge Group NY LLC Acquires 21,911 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Ally Bridge Group NY LLC lifted its holdings in shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 10.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 240,892 sharNovember 28, 2024 | marketbeat.comBright Minds initiated at outperform by Baird, Longboard takeover citedNovember 26, 2024 | msn.comJennison Associates LLC Sells 34,440 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Jennison Associates LLC lowered its position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 3.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 917,528 shares of the company's stock after selling 34,44November 22, 2024 | marketbeat.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Receives Average Recommendation of "Hold" from BrokeragesShares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) have earned a consensus recommendation of "Hold" from the nine research firms that are covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold recommendation and four have given a buNovember 22, 2024 | marketbeat.comBraun Stacey Associates Inc. Takes Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Braun Stacey Associates Inc. acquired a new stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 299,156 shares of the company's stockNovember 18, 2024 | marketbeat.comHold Rating for Longboard Pharmaceuticals Amidst Acquisition Uncertainty and Speculative RisksNovember 13, 2024 | markets.businessinsider.comLongboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)November 12, 2024 | finance.yahoo.comLongboard Pharmaceuticals Advances Neurological TreatmentsNovember 9, 2024 | markets.businessinsider.comLongboard Pharmaceuticals HSR waiting period expires for Lundbeck dealNovember 7, 2024 | msn.comLongboard Pharmaceuticals granted Orphan Drug Designation for bexicaserinNovember 5, 2024 | markets.businessinsider.comEmerald Advisers LLC Grows Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Emerald Advisers LLC raised its holdings in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 199.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 683,642 shares of the company's stock after acquiring an additional 455,119 shaNovember 3, 2024 | marketbeat.comLongboard Pharmaceuticals Inc options imply 0.8% move in share price post-earningsNovember 1, 2024 | markets.businessinsider.comLongboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 1-Year High - Here's What HappenedLongboard Pharmaceuticals (NASDAQ:LBPH) Sets New 52-Week High - Time to Buy?November 1, 2024 | marketbeat.comLONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc. - LBPHOctober 31, 2024 | businesswire.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of "Hold" by AnalystsShares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) have received a consensus rating of "Hold" from the nine ratings firms that are covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation and four have issued a buOctober 28, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Sets New 12-Month High - Here's What HappenedLongboard Pharmaceuticals (NASDAQ:LBPH) Sets New 52-Week High - Should You Buy?October 23, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading Volume - Should You Buy?Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Strong Trading Volume - What's Next?October 21, 2024 | marketbeat.comSG Americas Securities LLC Buys Shares of 10,514 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)SG Americas Securities LLC bought a new stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 10,514 shares of the company's stock, valued at approximately $350,000. Other lOctober 19, 2024 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH and ARC on Behalf of ShareholdersOctober 17, 2024 | globenewswire.comHC Wainwright & Co. Downgrades Longboard Pharmaceuticals (LBPH)October 17, 2024 | msn.comRandall Kaye Sells 16,667 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) StockOctober 17, 2024 | insidertrades.comStrong Valuation and Strategic Acquisition Drive Buy Rating for Longboard PharmaceuticalsOctober 16, 2024 | markets.businessinsider.comTruist Securities Downgrades Longboard Pharmaceuticals (LBPH)October 16, 2024 | msn.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc. – LBPHOctober 16, 2024 | globenewswire.comWedbush Lowers Longboard Pharmaceuticals (NASDAQ:LBPH) to HoldWedbush downgraded Longboard Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a research report on Monday.October 16, 2024 | marketbeat.comLONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc. - LBPHOctober 15, 2024 | businesswire.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest UpdateLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 5,380,000 shares, a growth of 33.5% from the September 15th total of 4,030,000 shares. Currently, 16.0% of the company's shares are short sold. Based on an average trading volume of 655,600 shares, the days-to-cover ratio is presently 8.2 days.October 15, 2024 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH and OB on Behalf of ShareholdersOctober 15, 2024 | globenewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc. - LBPHOctober 15, 2024 | prnewswire.comLongboard Pharmaceuticals (NASDAQ:LBPH) Sees Large Volume Increase - Here's WhyLongboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading Volume - Still a Buy?October 15, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Given Neutral Rating at HC WainwrightHC Wainwright reaffirmed a "neutral" rating and set a $60.00 price target (down previously from $80.00) on shares of Longboard Pharmaceuticals in a research report on Tuesday.October 15, 2024 | marketbeat.comLongboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by LundbeckOctober 14, 2024 | msn.comLundbeck to acquire Longboard Pharmaceuticals in $2.6B dealOctober 14, 2024 | finance.yahoo.comM&A News: Lundbeck to Acquire Longboard (NASDAQ:LBPH) for $2.6BOctober 14, 2024 | msn.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Longboard Pharmaceuticals, Inc.October 14, 2024 | prnewswire.comLongboard Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:LBPH)Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) saw unusually large options trading on Monday. Traders bought 4,265 call options on the company. This represents an increase of 1,960% compared to the average volume of 207 call options.October 14, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Earns Neutral Rating from B. RileyB. Riley restated a "neutral" rating and set a $60.00 price objective (up from $45.00) on shares of Longboard Pharmaceuticals in a research report on Monday.October 14, 2024 | marketbeat.comLongboard Pharmaceutical Stock Soars 51%. It's Being Bought for $2.6 Billion.October 14, 2024 | barrons.comShareholder Alert: Ademi LLP Investigates Whether Longboard Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public ShareholdersOctober 14, 2024 | businesswire.comLBPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Longboard Pharmaceuticals, Inc. Is Fair to ShareholdersOctober 14, 2024 | businesswire.comLundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience PipelineOctober 14, 2024 | businesswire.com Get Longboard Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter. Email Address LBPH Media Mentions By Week LBPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LBPH News Sentiment▼0.000.60▲Average Medical News Sentiment LBPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LBPH Articles This Week▼03▲LBPH Articles Average Week Get Longboard Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies QGEN News Today ASND News Today ROIV News Today RVMD News Today LEGN News Today BBIO News Today AXSM News Today BPMC News Today TLX News Today ELAN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LBPH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longboard Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longboard Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
